US 6565827
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired A61KA61K2039/505A61K51/1069
Quick answer
US patent 6565827 (Radioimmunotherapy of lymphoma using anti-CD20 antibodies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K51/1069